Oculocardiac Reflex

1

Review clinical trials related to Oculocardiac Reflex. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Two Intravenous Doses of Ketamine in Reducing the Oculocardiac Reflex in Adult Patients Undergoing Ophthalmic Surgery

This study aims to evaluate whether a lower dose of ketamine (0.5 mg/kg IV) may be as effective as a higher dose (0.75 mg/kg IV) in reducing oculocardiac reflex (OCR) incidence in adult patients undergoing ophthalmic surgery.

Participants needed: 40
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Cairo UniversityUpdated: Jul 16, 2026Locations: 1
Eligibility criteria

Age from 18 to 65 years old. [+3]

Ketamine contraindications (e.g., hypersensitivity, uncontrolled hypertension) [+4]